| Preface |
ix |
| |
Acknowledgements |
xi |
| Chapter 1 |
Introduction |
1 |
| |
The Business of Diagnostic
Testing
|
1 |
| |
Quality Has Improved--Yet
Physicians Rely More on Test Results
|
1 |
| |
Lifescan: One
Manufacturer's Problem
|
1 |
| |
University of Washington
Medical Center: A Laboratory Problem
|
2 |
| |
Analysis of the Two
Problems
|
2 |
| |
Why Problems Occur
|
3 |
| |
Financial Incentives Don't
Favor Allocating Resources to Quality
|
3 |
| |
Industry-supported Studies
Favor Low-information-content Reports
|
4 |
| |
Corporate Culture
|
4 |
| |
Inertia
|
4 |
| |
How This Book Can Help
|
5 |
| Appendix |
The Role of Assay Error in
Decisions to Approve Assays for Use |
6 |
| Chapter 2 |
The Diagnostic Assay Development
Landscape and the Role of Consultants |
7 |
| |
The Technical Environment
|
7 |
| |
The Commercial Environment
|
8 |
| |
The Regulatory and Medical
Environment
|
8 |
| |
The Management Environment
|
8 |
| |
The Five Stages of Product
Development
|
9 |
| |
The Consultant's
Environment--How Consultants Get Their Solutions
Implemented
|
10 |
| |
How Statisticians Are Often
Perceived and What They Really Do
|
10 |
| |
When Management
Resists--Techniques Used by Consultants to Implement
Solutions
|
11 |
| |
It's About Control
|
12 |
| |
The Successful Consulting
Cycle
|
13 |
| |
Technology Transfer--The
Benefits of a Learning Organization
|
13 |
| |
Training as Part of a
Learning Organization
|
14 |
| Chapter 3 |
Stage I: Researching New
Opportunities |
17 |
| |
Why Scientists and
Engineers Need to Understand Financial Models
|
17 |
| |
Using
Decision-analysis-based Financial Models to Value
Opportunities
|
18 |
| |
Decision-analysis
Background and Terms
|
18 |
| |
Selecting Decision-analysis
Software
|
19 |
| |
Creating the
Decision-analysis Team
|
19 |
| |
Preparing an Influence
Diagram
|
19 |
| |
Techniques to Solicit
Unbiased Data
|
21 |
| |
Performing the
Analysis--The Results
|
22 |
| |
The Base Case
|
22 |
| |
Sensitivity Analysis
|
22 |
| |
Distribution Analysis
|
23 |
| |
Techniques to Improve
Decision-analysis Models
|
24 |
| |
The Use of Options
|
24 |
| |
Markov Analysis
|
25 |
| |
Methods to Evaluate the
Probability of the Technical Success of Opportunities
|
27 |
| |
Different States of
Knowledge Require Different Strategies
|
28 |
| |
Results Based on Decision
Analysis
|
28 |
| |
Why Management Always Wants
the Product Released Sooner
|
28 |
| |
Why Quality Ranks Low in
Terms of Financial Rewards
|
30 |
| |
Portfolio Analysis
|
31 |
| |
A Caveat About Using
Decision Analysis
|
31 |
| Appendix |
How Expected NPVs Are Calculated |
31 |
| Chapter 4 |
Stage II: Proving Feasibility |
33 |
| |
Setting Performance
Specifications Using Quantitative Methods
|
33 |
| |
The Importance of Adequate
Performance Specifications
|
33 |
| |
Adequate and
Less-than-adequate Performance Specifications
|
34 |
| |
Nonexistent Specifications
|
34 |
| |
Nonquantitative
Specifications
|
35 |
| |
Unrealistic Specifications
|
35 |
| |
Incorrect Specifications
|
36 |
| |
Specifications Without an
Associated Testing and Analysis Method
|
36 |
| |
Characteristics of an
Adequate Performance Specification
|
37 |
| |
An Example of a Performance
Specification for Blood Gas Analyzer Glucose Imprecision
|
37 |
| |
How Specifications Change
Through the Development Process
|
37 |
| |
Different Origins of
Performance Specifications
|
37 |
| |
Regulatory
|
38 |
| |
Medical Need
|
38 |
| |
Competitive
|
38 |
| |
How Specifications Are Used
Differently by Manufacturers and Customers
|
39 |
| |
Specific Techniques Used to
Set Performance Specifications
|
40 |
| |
Focus Groups and Surveys
|
40 |
| |
Conjoint Analysis
|
41 |
| |
Quality Function Deployment
|
42 |
| |
Different Approaches to
Demonstrating Feasibility
|
45 |
| |
Beware the Technical
Administrator
|
45 |
| Chapter 5 |
Stage III: Scheduled Development |
49 |
| |
Why Products Are Almost
Always Late
|
49 |
| |
Using Design of Experiments
Methods to Build Robust Assays
|
52 |
| |
Why Many Scientists Do not
Use Design of Experiments (DOE) Methods
|
52 |
| |
Cause-and-effect Diagrams
and Process Flow Charts
|
53 |
| |
Factorial and
Response-surface Methods
|
54 |
| |
Experiment-planning
Checklist
|
56 |
| |
Writing Reports That
Convert Data into Information
|
57 |
| |
The Need for Written
Reports
|
57 |
| |
Tips for Converting Data
into Information
|
57 |
| |
A Suggested Report Format
|
58 |
| |
Symptoms for Problem
Reports
|
59 |
| |
Using Reliability Growth
Management to Build Reliable Systems
|
59 |
| |
An Overview of Reliability
Growth Management
|
60 |
| |
When "Testing in Quality"
Is More Efficient Than "Designing in Quality"
|
61 |
| |
A Model of Instrument
System Service Calls
|
61 |
| |
Redundancy and Reliability
Goals
|
62 |
| |
FRACAS
|
62 |
| |
Data Analysis
|
63 |
| |
Corrective Action
|
63 |
| |
Measuring Progress
|
64 |
| |
Results Achieved with
Reliability Growth Management
|
66 |
| Chapter 6 |
Stage IV: Validation |
69 |
| |
Why Many Published
Validation Methods Fall Short in Assessing Assay Quality
|
69 |
| |
Validation Methods Within
Companies
|
69 |
| |
Error Modeling Using
Simulation
|
69 |
| |
A Block Diagram or Flow
Chart of the System
|
70 |
| |
A Cause-and-effect Diagram
of Error
|
70 |
| |
How the Error Model Works
|
71 |
| |
The Simulation Software
|
72 |
| |
Total Analytical Error
|
72 |
| |
Multifactor Protocols
|
76 |
| |
Introduction
|
76 |
| |
Multifactor Protocol
History
|
76 |
| |
Understanding Multifactor
Protocols
|
76 |
| |
Use and Interpretation of
Multifactor Protocols
|
79 |
| |
Examples
|
79 |
| |
Implementation
|
82 |
| |
Additional Special Studies
|
82 |
| |
Diagnostic Accuracy
|
82 |
| |
The Detection Limit
|
83 |
| |
Specific Interference
Studies
|
83 |
| |
Direct vs. Indirect Methods
of Estimation
|
83 |
| |
Estimation of Outliers
|
83 |
| |
Outlier Goals
|
84 |
| |
Estimation of Outlier Rates
|
85 |
| |
External (Customer)
Validation Methods
|
88 |
| |
Why Manufacturer Trials
Held at Customer Sites Often Fail to Detect Problems
|
88 |
| Chapter 7 |
Stage V: Commercialization |
91 |
| |
How Claims Differ from
Internal Specifications
|
91 |
| |
The Typical Data Claim
|
91 |
| |
The Guaranteed Performance
Claim
|
92 |
| |
Obtaining and Analyzing
Remote Data
|
93 |
| |
Fault Detection
|
93 |
| |
Data Collection
|
93 |
| |
Data Analysis
|
94 |
| |
The Mean Cumulative Repair
Function
|
94 |
| |
Using Process Capability to
Compare Performance Across Assays
|
96 |
| |
The Difference Between
Quality Control and Process Capability
|
97 |
| |
An Example Set of Assays
Compared
|
97 |
| |
Interpretation
|
98 |
| |
Using Complaints to Improve
Assays
|
101 |
| |
Index |
103 |